4 results about "Adverse health effect" patented technology

Herbal Composition for Activation of the Endocannabinoid System The present invention relates to herbal compositions and methods to activate the endocannabinoid system in order to alleviate stress and its attendant adverse health effects.

The invention belongs to the technical field of detection, and particularly relates to an ammonium fluoride detection method and application. The method comprises the following steps: detecting the content of free acid in an ammonium fluoride aqueous solution and / or the content of ammonium fluoride by adopting a potentiometric titration method, recording a potential jump point in the detection process, measuring the consumption of a titration solution, and calculating to obtain the concentration of free acid (hydrofluoric acid) and / or the concentration of ammonium fluoride. The detection method disclosed by the invention overcomes the defects of environmental pollution and influence on body health caused by the fact that formaldehyde needs to be added to promote H < + > release in a traditional acid-base titration method; and meanwhile, the problem of inaccurate detection result of incompletely ionized weak acid and weak base salt by potentiometric titration is solved. According to the technical scheme, detection is accurate and efficient, the obtained concentration content result is more accurate compared with manual titration, and the method is particularly suitable for in-plant and out-plant detection of electronic-grade ammonium fluoride.

Disclosed herein are materials, articles of manufacture, and methods for decreasing, mitigating, removing or precluding formation of an amount of a nitrosating agent and / or an N-nitroso compound, including an N-nitrosamine, in an enclosure of a pharmaceutical drug package to inhibit a potential adverse health effect on a patient associated with the nitrosating agent or N-nitroso compound. The package contains an active agent and a pharmaceutical dosage form in an enclosure of the package. The active agent is effective to decrease, mitigate, remove or preclude the formation of an amount of the nitrosating agent and / or N-nitroso compound in the enclosure and / or in the pharmaceutical dosage form. Also provided are drug delivery systems including a blister pack configured to house multiple pharmaceutical dosage forms, the blister pack including an active agent as discussed above.

A frozen coffee custard hybrid product is disclosed, along with several formulations and manufacturing methods. A single product serving has a caffeine content equivalent to a serving of coffee, and formulations are provided using various dairy, fiber, and sweetener sources that are combined to create a creamy and smooth texture similar to premium ice cream. As a frozen product, consumers can enjoy their daily serving of coffee by simply opening the freezer. Additionally, the formulations utilize natural sweeteners to mitigate the adverse health effects of consuming processed sugars and fiber to improve digestive and heart health. The preferred embodiment discloses a frozen coffee custard hybrid product comprising whole milk in an amount in the range of 25 to 75 wt. %, heavy cream in an amount in the range of 5 to 20 wt. %, skim powder in an amount in the range of 0.5 to 5 wt. %, an emulsifier in an amount in the range of 1 to 20 wt. %, sweetener in an amount in the range of 10 to 30 wt. %, and coffee in an amount in the range of 0.8 to 5 wt. %.